शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BLUEJETNSEBlue Jet Healthcare Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Mon, 25 May, 2026 · 12:40 IST

Blue Jet Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2026, recommended Final Dividend of Rs. 1.20 per equity share.

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+10.2%Reaction day
₹439.00
prior close
₹463.00
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.2%+9.0% vs market
Pharmaceuticals peers, median of 166sector+0.8%+9.4% vs sector

On the reaction day the stock moved 9.0 pts more than Nifty Smallcap 250 and 9.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.6
10m
+2.3
15m
+4.3
30m
+2.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+10.2+1.2+9.0+0.8+9.4
Next day
+13.7+1.4+12.3+1.4+12.3
2d
+7.5+2.0+5.6+1.4+6.1
3d
+3.2+1.3+1.9+0.8+2.5
4d
+1.7+0.5+1.2+0.4+1.3
5d
+3.5+1.0+2.5+0.8+2.7
1w
+8.2+1.7+6.5+0.5+7.7
15d
+16.4+3.5+12.9+1.3+15.1
1m
+19.6+5.5+14.0+3.4+16.2
2m
+31.9+6.3+25.6+5.5+26.3
3m
+34.9+9.4+25.5+8.2+26.6
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare's Board recommended a final dividend of Rs. 1.20 per equity share (60% payout) for FY 2025-26, subject to shareholder approval at the ensuing AGM. The company's annual profit declined to Rs. 2,478.16 million from Rs. 3,052.03 million in FY25, while total income fell to Rs. 10,159.75 million from Rs. 10,762.41 million. Profit before tax stood at Rs. 3,325.12 million versus Rs. 4,060.99 million the prior year. The Board also approved a proposal to raise funds up to Rs. 10,000 million (Rs. 1,000 crore) through QIP, preferential issues, private placements, or other methods. Record date and dividend payment date are yet to be announced.

Likely market impact

The 19% profit decline despite dividend continuity suggests resilience in cash generation, but investors should monitor the proposed capital raise which could dilute earnings per share. The fund-raising plan needs shareholder and regulatory approvals.